Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Daniel Kelly

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVIDMichael J Peluso, Tyler-Marie Deveau, Sadie E Munter, et al.
AIDS (London, England)|July 22, 2022
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infectionMichael J Peluso, Matthew A Spinelli, Tyler-Marie Deveau, et al.
Science Translational Medicine|July 3, 2024
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infectionMichael J Peluso, Dylan Ryder, Robert R Flavell, et al.
The Journal of Infectious Diseases|January 27, 2023
Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020-2022Jessica E Deyoe, J Daniel Kelly, Carlos G Grijalva, et al.
Plos Pathogens|September 12, 2022
Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort studyMiguel Garcia-Knight, Khamal Anglin, Michel Tassetto, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Nature|July 19, 2023
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infectionDanillo G Augusto, Lawton D Murdolo, Demetra S M Chatzileontiadou, et al.
Cell Reports. Medicine|July 15, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2025
Long-COVID incidence proportion in adults and children between 2020 and 2024Hannah Mandel, Yun J Yoo, Andrea J Allen, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVIDMichael J Peluso, Tyler-Marie Deveau, Sadie E Munter, et al.
AIDS (London, England)|July 22, 2022
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infectionMichael J Peluso, Matthew A Spinelli, Tyler-Marie Deveau, et al.
Science Translational Medicine|July 3, 2024
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infectionMichael J Peluso, Dylan Ryder, Robert R Flavell, et al.
The Journal of Infectious Diseases|January 27, 2023
Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020-2022Jessica E Deyoe, J Daniel Kelly, Carlos G Grijalva, et al.
Plos Pathogens|September 12, 2022
Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort studyMiguel Garcia-Knight, Khamal Anglin, Michel Tassetto, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Nature|July 19, 2023
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infectionDanillo G Augusto, Lawton D Murdolo, Demetra S M Chatzileontiadou, et al.
Cell Reports. Medicine|July 15, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2025
Long-COVID incidence proportion in adults and children between 2020 and 2024Hannah Mandel, Yun J Yoo, Andrea J Allen, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Pageof 14